Speciality: Infectious diseases
Description:
A warm welcome to all the medical practitioners in this interesting session on ideal, possible and futuristic options of syndromic testing and antimicrobial stewardship practices.
The speaker Dr. P. Senthur Nambi has provided elaborative knowledge on the ideal, possible and futuristic prospects of syndromic diagnostic testing and antimicrobial stewardship.
Syndromic diagnostic testing is a novel approach of rapid diagnosis of common infectious diseases which include bloodstream, respiratory, gastrointestinal, and CNS infections. As the threat of antimicrobial resistance continues to rise globally, it is extremely important to focus on the judicious use of antimicrobials.
The ideal patient for a syndromic test may be patients who are immunocompromised, critically ill, or a pediatric patient, or the ones for whom immediate pathogen identification is essential. Therefore, antimicrobial stewardship helps in appropriate use of antimicrobials for setting guidance in patient management in order to optimize clinical outcomes and minimize complications.
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Beyond What Is Visible in Myelofibrosis?
2.
FDA approves rivanetin as the first-line treatment for lung cancer.
3.
In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.
4.
New First-Line Option for Advanced ALK-Positive Lung Cancer
5.
Certain surgical gestures during prostate removal linked to better sexual function recovery
1.
Tremelimumab: A Potential Breakthrough in Cancer Treatment
2.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
3.
Artificial Intelligence for Early Cancer Detection Leveraging Multi-Omics: A Comprehensive Review
4.
Harnessing Snake Venom in Hematology: From Toxins to Life-Saving Therapeutics
5.
Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
3.
Updates on Standard V/S High Risk Myeloma Treatment
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation